AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 81 filers reported holding AVROBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,000 | -67.9% | 18,810 | -6.6% | 0.00% | – |
| Q4 2021 | $78,000 | -32.8% | 20,134 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $116,000 | -35.9% | 20,737 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $181,000 | -31.2% | 20,326 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $263,000 | +4.0% | 20,710 | +14.0% | 0.00% | 0.0% |
| Q4 2020 | $253,000 | +4.1% | 18,160 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $243,000 | -26.4% | 18,682 | -1.1% | 0.00% | -50.0% |
| Q2 2020 | $330,000 | +52.8% | 18,892 | +36.1% | 0.00% | +100.0% |
| Q1 2020 | $216,000 | -16.9% | 13,877 | +7.5% | 0.00% | 0.0% |
| Q4 2019 | $260,000 | +41.3% | 12,904 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $184,000 | +13.6% | 13,013 | +30.5% | 0.00% | 0.0% |
| Q2 2019 | $162,000 | -9.5% | 9,972 | +22.9% | 0.00% | 0.0% |
| Q1 2019 | $179,000 | +167.2% | 8,111 | +102.2% | 0.00% | – |
| Q4 2018 | $67,000 | -68.1% | 4,011 | -0.7% | 0.00% | -100.0% |
| Q3 2018 | $210,000 | – | 4,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |